CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Opicapone

奥匹卡朋 杂质对照品Opicapone Impurities

34 个杂质条目34 impurity entries

本页汇总 奥匹卡朋 的 34 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Opicapone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 奥匹卡朋(Opicapone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment of a liquid chromatography assay for the determination of opicapone and BIA 9-1079 in rat matrices
    Biomedical chromatography : BMC · 2016 · Gonçalves D et al.  ·  PMID 26147707  ·  DOI
  2. 分析方法Analytical MethodsAn HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma
    The Analyst · 2013 · Gonçalves D et al.  ·  PMID 23476919  ·  DOI

奥匹卡朋 —— 原料药与杂质对照品Opicapone — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Opicapone structure
原料药 APIAPI
奥匹卡朋Opicapone
Opicapone
CAS No.923287-50-7
Chemical FormulaC15H10Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 1 (Opicapone Sulfate) structure
1
奥匹卡朋杂质1(硫酸奥匹卡朋)Opicapone Impurity 1 (Opicapone Sulfate)
Opicapone Impurity 1 (Opicapone Sulfate)
CAS No.1428009-72-6
Chemical FormulaC15H10Cl2N4O9S
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 2 structure
2
奥匹卡朋杂质2Opicapone Impurity 2
Opicapone Impurity 2
CAS No.91591-66-1
Chemical FormulaC9H9ClN2O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 6 structure
6
奥匹卡朋杂质6Opicapone Impurity 6
Opicapone Impurity 6
CAS No.175204-44-1
Chemical FormulaC8H8Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 7 structure
7
奥匹卡朋杂质7Opicapone Impurity 7
Opicapone Impurity 7
CAS No.893767-99-2
Chemical FormulaC8H8ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 10 structure
10
奥匹卡朋杂质10Opicapone Impurity 10
Opicapone Impurity 10
CAS No.121-34-6
Chemical FormulaC8H8O4
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 12 structure
12
奥匹卡朋杂质12Opicapone Impurity 12
Opicapone Impurity 12
CAS No.874518-62-4
Chemical FormulaC10H10O5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 15 structure
15
奥匹卡朋杂质15Opicapone Impurity 15
Opicapone Impurity 15
CAS No.2824922-36-1
Chemical FormulaC16H13Cl2N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 17 structure
17
奥匹卡朋杂质17Opicapone Impurity 17
Opicapone Impurity 17
CAS No.1391712-50-7
Chemical FormulaC16H12Cl2N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 18 structure
18
奥匹卡朋杂质18Opicapone Impurity 18
Opicapone Impurity 18
CAS No.952091-17-7
Chemical FormulaC15H10Cl2N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 27 structure
27
奥匹卡朋杂质27Opicapone Impurity 27
Opicapone Impurity 27
CAS No.1402714-41-3
Chemical FormulaC16H12Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 28 structure
28
奥匹卡朋杂质28Opicapone Impurity 28
Opicapone Impurity 28
CAS No.890092-32-7
Chemical FormulaC8H7ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 29 structure
29
奥匹卡朋杂质29Opicapone Impurity 29
Opicapone Impurity 29
CAS No.89942-87-0
Chemical FormulaC8H7NO6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 30 structure
30
奥匹卡朋杂质30Opicapone Impurity 30
Opicapone Impurity 30
CAS No.2356241-51-3
Chemical FormulaC17H14Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 31 structure
31
奥匹卡朋杂质31Opicapone Impurity 31
Opicapone Impurity 31
CAS No.1443319-15-0
Chemical FormulaC8H6ClNO5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 33 structure
33
奥匹卡朋杂质33Opicapone Impurity 33
Opicapone Impurity 33
CAS No.91591-63-8
Chemical FormulaC8H6Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 34 structure
34
奥匹卡朋杂质34Opicapone Impurity 34
Opicapone Impurity 34
CAS No.91004-48-7
Chemical FormulaC9H9NO6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 35 structure
35
奥匹卡朋杂质35Opicapone Impurity 35
Opicapone Impurity 35
CAS No.2356241-50-2
Chemical FormulaC17H14Cl2N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 36 structure
36
奥匹卡朋杂质36Opicapone Impurity 36
Opicapone Impurity 36
CAS No.1402714-30-0
Chemical FormulaC15H11ClN4O6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 37 structure
37
奥匹卡朋杂质37Opicapone Impurity 37
Opicapone Impurity 37
CAS No.1402714-32-2
Chemical FormulaC16H13ClN4O7
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 38 structure
38
奥匹卡朋杂质38Opicapone Impurity 38
Opicapone Impurity 38
CAS No.1402714-38-8
Chemical FormulaC15H9Cl3N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 39 structure
39
奥匹卡朋杂质39Opicapone Impurity 39
Opicapone Impurity 39
CAS No.1402714-34-4
Chemical FormulaC15H9Cl3N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 40 structure
40
奥匹卡朋杂质40Opicapone Impurity 40
Opicapone Impurity 40
CAS No.2581230-73-9
Chemical FormulaC8H6Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 41 structure
41
奥匹卡朋杂质41Opicapone Impurity 41
Opicapone Impurity 41
CAS No.1378698-37-3
Chemical FormulaC8H9ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 47 structure
47
奥匹卡朋杂质47Opicapone Impurity 47
Opicapone Impurity 47
CAS No.1402714-31-1
Chemical FormulaC15H11ClN4O7
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 49 structure
49
奥匹卡朋杂质49Opicapone Impurity 49
Opicapone Impurity 49
CAS No.64095-07-4
Chemical FormulaC10H11NO6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 50 structure
50
奥匹卡朋杂质50Opicapone Impurity 50
Opicapone Impurity 50
CAS No.1402714-39-9
Chemical FormulaC16H11Cl3N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 55 structure
55
奥匹卡朋杂质55Opicapone Impurity 55
Opicapone Impurity 55
CAS No.2824922-39-4
Chemical FormulaC15H11Cl2N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 58 structure
58
奥匹卡朋杂质58Opicapone Impurity 58
Opicapone Impurity 58
CAS No.101320-87-0
Chemical FormulaC7H4Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 59 structure
59
奥匹卡朋杂质59Opicapone Impurity 59
Opicapone Impurity 59
CAS No.2581230-78-4
Chemical FormulaC8H6Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 65 structure
65
奥匹卡朋杂质65Opicapone Impurity 65
Opicapone Impurity 65
CAS No.1428009-74-8
Chemical FormulaC21H18Cl2N4O12
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 66 structure
66
奥匹卡朋杂质66Opicapone Impurity 66
Opicapone Impurity 66
CAS No.923288-59-9
Chemical FormulaC8H9Cl2N3O
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 67 structure
67
奥匹卡朋杂质67Opicapone Impurity 67
Opicapone Impurity 67
CAS No.1962082-05-8
Chemical FormulaC11H10N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 69 structure
69
奥匹卡朋杂质69Opicapone Impurity 69
Opicapone Impurity 69
CAS No.923287-46-1
Chemical FormulaC15H11ClN4O6
Purity>95%询价On request
10mg25mg50mg100mg
Opicapone Impurity 71 structure
71
奥匹卡朋杂质71Opicapone Impurity 71
Opicapone Impurity 71
CAS No.1428009-81-7
Chemical FormulaC16H12Cl2N4O6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

奥匹卡朋 杂质谱研究要点Opicapone — impurity profiling notes

下面这些是拿到 奥匹卡朋 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Opicapone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances